Pfizer is proud to offer the 2015 ASPIRE Rheumatology and Dermatology Research Awards

This ASPIRE program is part of Pfizer's commitment to supporting research in autoimmune diseases within rheumatology and dermatology.

Mission

The mission of the ASPIRE program is to fund high quality basic science, translational and clinical research through a competitive grants program that advances medical knowledge in the epidemiology, pathogenesis and treatment of selected diseases.

Background

Scientific research continues to advance our knowledge and understanding of autoimmune diseases within rheumatology and dermatology. The 2015 ASPIRE Rheumatology and Dermatology Research Awards will fund meritorious research proposals focusing on rheumatoid arthritis and plaque psoriasis that have the potential to improve patient care.

Areas of Focus

Research areas of interest in rheumatoid arthritis and plaque psoriasis are as follows:

General Rheumatoid Arthritis Plaque Psoriasis

Available Awards

ASPIRE Rheumatology and Dermatology research awards are up to a maximum of $150,000 each. Research projects are expected to complete within 2 years of study start. Larger grants may be considered depending on scope and merit of proposal.